Search the Newsreel

FDMT (NASDAQ: FDMT) stockholder schedules 1,635-share sale after option exercise

A stockholder of 4D Molecular Therapeutics, Inc. (FDMT) has filed to sell 1,635 common shares on NASDAQ, to be issued through the exercise of stock options for cash on August 13, 2026. This filing also discloses previous Rule 10b5-1 plan sales by Scott Bizily …

4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones

4D Molecular Therapeutics (4DMT) reported its Q2 2026 financial results, highlighting significant progress in its clinical programs for wet AMD and DME, including completed enrollment for two Phase 3 trials for 4D-150 and strong two-year data from its PRISM Phase 2b study. The company …

Costco (COST) Debuts Reusable Tote Trio In West Coast Stores And Online Soon

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Costco Wholesale (NasdaqGS:COST) is rolling out Out Of The Woods LLC's XL Tote Trio reusable bag set in select West Coast warehouses, with online availability …

Transcript : Finolex Cables Limited, Q1 2027 Earnings Call, Aug 13, 2026

Red Violet stock hits all-time high at 72.97 USD

Red Violet (RDVT) stock has reached an all-time high of $72.97, reflecting a significant 65.96% increase over the past year. The company reported strong Q2 2026 financial results, with adjusted earnings of $0.50 per share and revenue of $26.72 million, surpassing analyst expectations. Despite …

Costco Is Priced Like The Best Of Its Group. Is It?

Costco's stock trades at a premium valuation compared to its peers, despite having lower operating margins and not leading in revenue growth. The market attributes this premium to its strong membership model, which generates recurring revenue and fosters customer loyalty, allowing the company to …

Mettler Toledo Introduces Rapid Inspection Systems Delivery System

Mettler Toledo Product Inspection Group has launched LightningBuild, a program offering select product inspection systems with a four-week delivery time. This initiative includes the X12 LightningBuild X-ray inspection system and the C31 LightningBuild checkweigher, aiming to help food and pharmaceutical manufacturers quickly adapt to …

4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates

4D Molecular Therapeutics, Inc. (FDMT) reported a Q2 loss of $1.04 per share, matching Zacks Consensus Estimate, but surpassed revenue estimates significantly with $3.78 million, beating expectations by 142.37%. The company's stock has performed well year-to-date, rising 58.3% against the S&P 500's 13.2% gain, …

Ratio Petroleum Energy - Limited Partnership Reports Earnings Results for the Half Year Ended June 30, 2026

BrightFarms Brings Georgia-Grown Salad Greens to Atlanta-Area Costco Stores

Locally grown lettuce from Macon greenhouse offers Atlanta Metro shoppers a clean and fresh option harvested only an hour away. ATLANTA, Aug. 13, 2026 /PRNewswire/ -- As consumers continue to seek greater confidence in the safety and sourcing of their produce following recent Cyclospora …

Insight Molecular Diagnostics (IMDX) Drops 6.4% to $4.21 as Sellers Target $4.00 Support - Momentum Stock Picks

What Marathon Petroleum (MPC)'s Margin‑Fueled Q2 Profit Surge and Payouts Mean For Shareholders

Costco Shares Unaffected After $14 Million Email Lawsuit Settlement Equals 0.6% of Quarterly Earnings

JPMorgan Chase & Co. Issues Pessimistic Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price

DOLE vs. CTVA: Which Stock Is the Better Value Option?

Investors looking for stocks in the Agriculture - Operations sector might want to consider either Dole (DOLE) or Corteva, Inc. (CTVA). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer …

Molecular Partners AG (MOLNZ.XC) stock price, news, quote and history

J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46

J.P. Morgan has reiterated its Buy rating on Olema Pharmaceuticals (OLMA.US) and set a price target of $46. This indicates a positive outlook from the firm regarding the company's future performance.

Olectra Greentech Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH)

Moolec Science SA Warrants (MLECW) Live Share Price, Invest From India

This article provides live share price information and investment details for Moolec Science SA Warrants (MLECW), trading on NASDAQ. It includes current stock performance, historical returns, key fundamentals, and quarterly and annual profit and loss statements. The company develops food ingredients using molecular farming …

red violet to Present at the Midwest IDEAS Investor Conference

Red Violet, Inc. (NASDAQ: RDVT) announced it will present at the Midwest IDEAS Investor Conference in Chicago on August 26-27, 2026. Camilo Ramirez, Senior Vice President of Finance and Investor Relations, will host investor meetings and present on August 27, 2026. Red Violet is …

Form 8K Olema Pharmaceuticals Inc For: 13 August By Investing.com

This article announces the filing of a Form 8K by Olema Pharmaceuticals Inc. on August 13. It includes the stock symbol OLMA and indicates a slight negative change in its price. The content provides a general news format from Investing.com with market data and …

Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH)

red violet executive to host investor meetings in Chicago Aug. 27

Red Violet (NASDAQ: RDVT) announced it will present at the Midwest IDEAS Investor Conference in Chicago from August 26-27, 2026. Camilo Ramirez, Senior Vice President of Finance and Investor Relations, will deliver the company's presentation and host investor meetings on August 27, 2026. The …

HC Wainwright Brokers Decrease Earnings Estimates for OLMA

Marathon Petroleum (MPC) Stock Looks Below Fair Value While Cash Flow Looks Fair

Mettler Toledo International (MTD) Reports Stronger Earnings, Is The Stock Fully Valued?

Olema Oncology’s New CFO Brings More Than Two Decades in Biotech

Olema Oncology (Nasdaq: OLMA) has appointed Jason O’Byrne as its new Chief Financial Officer, bringing over two decades of finance leadership experience in the biotech and pharmaceutical sectors. This appointment comes as the company approaches pivotal data from its OPERA-01 study and prepares for …

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

Olema Pharmaceuticals, Inc. (Olema Oncology) has appointed Jason O’Byrne, MBA, as its new Chief Financial Officer. O'Byrne brings over two decades of finance and operations leadership from high-growth biotechnology and pharmaceutical organizations, including roles at Vir Biotechnology, Caribou Biosciences, Audentes Therapeutics, and Genentech/Roche. His …

Handelsbanken Fonder AB Has $18.10 Million Stock Position in Mettler-Toledo International, Inc. $MTD

5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call

Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH

Red Violet (RDVT) Beat Quarterly Estimates, Is It Fully Priced?

4D Molecular Therapeutics Inc (FDMT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Moolec Science SA (MLEC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Projeções de Resultados: Costco Wholesale Corp (COST) — LPA e Crescimento de Receita